|
|
Volumn 313, Issue 5784, 2006, Pages 160-163
|
|
Selling the stem cell dream
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELLS AND CELL COMPONENTS;
EMBRYONIC DEVELOPMENT;
CLINICAL PROTOCOL;
CORD BLOOD STEM CELL TRANSPLANTATION;
DEVELOPING COUNTRY;
FETUS CELL;
HEALTH CARE COST;
HEALTH CARE FACILITY;
HEALTH CARE POLICY;
HUMAN;
INTERNET;
PRIORITY JOURNAL;
QUALITY CONTROL;
SHORT SURVEY;
STEM CELL TRANSPLANTATION;
TREATMENT INDICATION;
ADVERTIZING;
ARTICLE;
BONE MARROW TRANSPLANTATION;
CLINICAL TRIAL;
ETHICS;
EUROPE;
GOVERNMENT REGULATION;
LEGAL ASPECT;
NEUROLOGIC DISEASE;
PUBLISHING;
STANDARD;
UNITED STATES;
ADVERTISING;
BONE MARROW TRANSPLANTATION;
CLINICAL TRIALS;
CORD BLOOD STEM CELL TRANSPLANTATION;
EUROPE;
GOVERNMENT REGULATION;
HUMANS;
INTERNET;
NERVOUS SYSTEM DISEASES;
PUBLISHING;
STEM CELL TRANSPLANTATION;
UNITED STATES;
|
|
EID: 33746018957
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.313.5784.160 Document Type: Short Survey |
|
Times cited : (50)
|
|
References (0)
|